These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30821716)

  • 1. Sustained nicorandil administration reduces the infarct size in ST-segment elevation myocardial infarction patients with primary percutaneous coronary intervention.
    Wang S; Duan Y; Feng X; Liu L; Shi Z; Wang B; Xia C; Man W; Wang H; Zhao Z; Sun D
    Anatol J Cardiol; 2019 Mar; 21(3):163-171. PubMed ID: 30821716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].
    Wang ZQ; Chen MX; Liu DL; Zheng WX; Cao XZ; Chen H; Huang MF; Luo ZR
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):26-33. PubMed ID: 28100342
    [No Abstract]   [Full Text] [Related]  

  • 3. Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction.
    Qi Q; Niu J; Chen T; Yin H; Wang T; Jiang Z
    Med Sci Monit; 2018 May; 24():2767-2776. PubMed ID: 29726480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Nicorandil Administration on Infarct Size in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: The CHANGE Trial.
    Qian G; Zhang Y; Dong W; Jiang ZC; Li T; Cheng LQ; Zou YT; Jiang XS; Zhou H; A X; Li P; Chen ML; Su X; Tian JW; Shi B; Li ZZ; Wu YQ; Li YJ; Chen YD
    J Am Heart Assoc; 2022 Sep; 11(18):e026232. PubMed ID: 36073634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
    Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
    Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis.
    Niu X; Zhang J; Bai M; Peng Y; Sun S; Zhang Z
    BMC Cardiovasc Disord; 2018 Jan; 18(1):3. PubMed ID: 29320987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of nicorandil on ventricular arrhythmia in patients with acute ST-segment elevation myocardial infarction underwent emergent percutaneous coronary intervention treatment].
    Wang YP; Zhang Y; Sun YR; Sun ZG; Zuo ZK; Feng ZR; Chang FY; Xu YC; Chen BZ; Ye YY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Aug; 45(8):701-705. PubMed ID: 28851188
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical outcomes of nicorandil administration in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials.
    Geng N; Ren L; Xu L; Zou D; Pang W
    BMC Cardiovasc Disord; 2021 Oct; 21(1):488. PubMed ID: 34629058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intravenous application of nicorandil on area of myocardial infarction in patients with STEMI during the perioperative stage of PCI.
    Wang ZD; Li H; Liu M; Li P; Chen J; Liang XW; Zhu XZ; Liao W
    Clin Hemorheol Microcirc; 2021; 77(4):411-423. PubMed ID: 33386796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of nicorandil on microvascular function in patients with ST segment elevation myocardial infarction undergoing primary PCI.
    Kostic J; Djordjevic-Dikic A; Dobric M; Milasinovic D; Nedeljkovic M; Stojkovic S; Stepanovic J; Tesic M; Trifunovic Z; Zamaklar-Tifunovic D; Radosavljevic-Radovanovic M; Ostojic M; Beleslin B
    Cardiovasc Ultrasound; 2015 May; 13():26. PubMed ID: 26012474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-of-day at symptom onset was not associated with infarct size and long-term prognosis in patients with ST-segment elevation myocardial infarction.
    Sager HB; Husser O; Steffens S; Laugwitz KL; Schunkert H; Kastrati A; Ndrepepa G; Kessler T
    J Transl Med; 2019 May; 17(1):180. PubMed ID: 31142323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials.
    Kitakaze M; Asakura M; Kim J; Shintani Y; Asanuma H; Hamasaki T; Seguchi O; Myoishi M; Minamino T; Ohara T; Nagai Y; Nanto S; Watanabe K; Fukuzawa S; Hirayama A; Nakamura N; Kimura K; Fujii K; Ishihara M; Saito Y; Tomoike H; Kitamura S;
    Lancet; 2007 Oct; 370(9597):1483-93. PubMed ID: 17964349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
    Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left Ventricular Hypertrophy Is Associated With Increased Infarct Size and Decreased Myocardial Salvage in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Nepper-Christensen L; Lønborg J; Ahtarovski KA; Høfsten DE; Kyhl K; Ghotbi AA; Schoos MM; Göransson C; Bertelsen L; Køber L; Helqvist S; Pedersen F; Saünamaki K; Jørgensen E; Kelbæk H; Holmvang L; Vejlstrup N; Engstrøm T
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28069574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the Efficacy and Safety of Early Intracoronary Nicorandil Administration in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Gupta H; Parihar S; Tripathi VD
    Cureus; 2022 May; 14(5):e25349. PubMed ID: 35761910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous nicorandil during primary percutaneous coronary intervention in patients with ST-Elevation myocardial infarction: Rationale and design of the Clinical Efficacy and Safety of Intravenous Nicorandil (CLEAN) trial.
    Huang D; Wu H; Zhou J; Zhong X; Gao W; Ma Y; Qian J; Ge J
    Am Heart J; 2022 Feb; 244():86-93. PubMed ID: 34785173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time Delay, Infarct Size, and Microvascular Obstruction After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction.
    Redfors B; Mohebi R; Giustino G; Chen S; Selker HP; Thiele H; Patel MR; Udelson JE; Ohman EM; Eitel I; Granger CB; Maehara A; Ali ZA; Ben-Yehuda O; Stone GW
    Circ Cardiovasc Interv; 2021 Feb; 14(2):e009879. PubMed ID: 33440999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect on periprocedural myocardial infarction of intra-coronary nicorandil prior to percutaneous coronary intervention in stable and unstable angina.
    Hwang J; Lee HC; Kim BW; Yang MJ; Park JS; Park JH; Lee HW; Oh J; Choi JH; Cha KS; Hong TJ; Song S; Kim SP
    J Cardiol; 2013 Aug; 62(2):77-81. PubMed ID: 23731922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactically injection of Nicorandil to reduce no-reflow phenomenon during PCI in acute STEMI patients: Protocol of a double-blinded, randomized, placebo-controlled trial.
    An S; Huang H; Wang H; Jiang Y
    Medicine (Baltimore); 2021 Apr; 100(15):e25500. PubMed ID: 33847663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular events associated with nicorandil administration prior to primary percutaneous coronary intervention in patients with acute ST-segment elevated myocardial infarction: a systematic review and meta-analysis.
    Li J; Xu X; Zhou X; Dai J; Ma L; Chen C; Li X; Mao W
    Expert Opin Drug Saf; 2019 Jun; 18(6):537-547. PubMed ID: 31117845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.